Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Assisted Reproductive Technology (ART) Market to Reach USD 50.71 Billion by 2027 | Reports And Data

      This image opens in the lightbox

      News provided by

      Reports And Data

      03 Jun, 2020, 13:00 GMT

      Share this article

      Share this article


      - The rising awareness about possible artificial conception methodologies and increasing incidences of advanced maternal age are driving the demand for the market

      - Market Size – USD 24.21 Billion in 2019, Market Growth - CAGR of 9.9%, Market Trends – Growing health awareness

      NEW YORK, June 3, 2020 /PRNewswire/ -- The global Assisted Reproductive Technology (ART) market is forecast to reach USD 50.71 Billion by 2027, according to a new report by Reports and Data. Assisted reproductive technology (ART) is the treatment for infertility in which laboratory fusion of ovule extracted from the women ovaries and are mixed with the male sperms is performed. There has been a dramatic rise in the number of women who have their babies at age 35 and over in the past four decades. This progression started in the mid-1970's in the U.S. and has proceeded to grow slowly over time. Fifteen percent of birth-giving people today are 35 and older, up from 11% in 2002 and 8% in 1990. Thus, with the increasing trends of late pregnancies across different parts of the world the adoption of ovulation test kits is anticipated to grow significantly.

      Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. Moreover, growing awareness of ART and eliminated discomfort about pregnancy related disorders from social factors have contributed sufficient market boost of the ART procedures. According to the World Fertility Patterns statistics, Mexico's birth rates are about 2 kids per mother, well below the levels expected to support current Mexico's population. Brazil's birth rate is also smaller, at 1.75, close to that of 1.77 for Colombia. Costa Rica is also smaller, down from 1.66. These declining fertility rates can be threatening for woman and parents planning to conceive. Thus, more number of couples are approaching an artificial pregnancy method.

      Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1402 

      A big market limiting factor is the stringent rules and regulations. The transfer of multiple embryos in a single cycle increases the rates of multiple births. Due to the increased social costs and health risks associated with multiple births, legislation or guidelines from professional societies have been introduced in many countries. Also, moderate success rate, which decreases the market demand, is expected to act as a restraining factor on the global market in the years ahead.

      The COVID-19 impact:

      The recent outbreak of COVID-19 has impacted growth of the market as in several countries the IVF or other ART procedures are being postponed or cancelled. Many studies have stated that women trying to conceive through ART are vulnerable to infection due to lower immunity. The restricted movements and extreme shutdown of the market in developed as well as developing nations has resulted into reduction of couples approaching ART. However, various gynecologist are maintaining the routine or follow up of surrogate or couples enlisted under ART procedures by using digital platform, hence after a short span of declination in the growth the market is estimated to grow in later phase of scenario.

      Further key findings from the report suggest

      • North America dominated the market with a revenue of USD 9.13 billion in 2019. In North America, the embryo/egg banking segment accounted for 2.17 billion market revenue in 2019 and is anticipated to grow USD 3.70 billion in 2027. This can be due to their changing lifestyle and increased adoption of late pregnancy.
      • The segment of In-Vitro Fertilization (IVF) technology dominated the market. In 2019 the segment generated USD 21.68 billion in revenue. Access to government subsidized schemes and development of less cost intensive techniques of IVF is expected to drive the demand of ART in respective regions.
      • Other emerging types of ART such as Gamete-Intra Fallopian Transfer (GIFT) and Zygote-Intra Fallopian Transfer (ZIFT) are anticipated to increase at a significant CAGR from 2019 to 2027
      • The continuous growth in infertility is expected to create future opportunity revenue packets of the ART market.
      • Key participants in the ART market are Merck KGaA (Germany), Cooper Surgical (Denmark), Fujifilm Irvine Scientific (US), Vitroife AB (Sweden), Thermo Fisher Scientific (US), Celmatix, Inc. (US), Anecova (Switzerland), OvaScience (US), Ferring Pharmaceuticals (US), , and FertiPro N.V. (Belgium).

      To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/assisted-reproductive-technology-art-market

      For the purpose of this report, Reports and Data have segmented into the global Assisted Reproductive Technology market on the basis of procedure, technology, type, end use and region:

      Procedures Outlook (Revenue, USD Billion; 2017-2027)

      • Fresh Donor
      • Fresh Non-Donor
      • Frozen Donor
      • Frozen Non-Donor
      • Embryo/Egg Banking

      Technology Outlook (Revenue, USD Billion; 2017-2027)

      • In-Vitro Fertilization (IVF)
        • IVF Using Intra-Cytoplasmic Sperm Injection (ICSI)
        • IVF Without Using Intra-Cytoplasmic Sperm Injection (ICSI)
      • Pre-Implantation Genetic Screening (PGS)
      • Frozen Embryo Replacement (FER)
      • Others

      Type Outlook (Revenue, USD Billion; 2017-2027)

      • Artificial Insemination
      • Surrogacy
      • Ovulation Induction
      • Others

      Order Now: https://www.reportsanddata.com/checkout-form/1402

      End Use Outlook (Revenue, USD Billion; 2017-2027)

      • Fertility Clinics
      • Hospitals
      • Clinical Research
      • Others

      Regional Outlook (Revenue, USD Billion; 2017-2027)

      • North America
        • U.S
      • Europe
        • U.K
        • France
      • Asia Pacific
        • China
        • India
        • Japan
      • MEA
      • Latin America
        • Brazil

      Browse more similar reports on Diagnostics category by Reports And Data

      • Influenza Diagnostics Market: https://www.reportsanddata.com/report-detail/influenza-diagnostics-market
      • Infectious Disease Diagnostics Market: https://www.reportsanddata.com/report-detail/infectious-disease-diagnostics-market
      • In-Vitro Diagnostics (IVD) Quality Control Market: https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-market

        About Reports and Data 

        Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

        Contact Us:
        John W
        Head of Business Development
        Reports And Data | Web: www.reportsanddata.com 
        Direct Line: +1-212-710-1370  
        E-mail: sales@reportsanddata.com
        LinkedIn | Twitter | Blogs

        Logo: https://mma.prnewswire.com/media/1009077/Reports_And_Data_Logo.jpg 

        Modal title

        Contact PR Newswire

        • +44 (0)20 7454 5110
          from 8 AM - 5:30 PM GMT
        • General Enquiries
        • Media Enquiries
        • Partnerships

        Products

        • Explore Our Platform
        • Plan Campaigns
        • Create with AI
        • Distribute Press Releases
        • Report Results
        • Amplify Content

        About

        • About PR Newswire
        • About Cision
        • Careers
        • Accessibility Statement
        • APAC
        • APAC - Simplified Chinese
        • APAC - Traditional Chinese
        • Brazil
        • Canada
        • Czech
        • Denmark
        • Finland
        • France
        • Germany
        • India
        • Indonesia
        • Israel
        • Japan
        • Korea
        • Mexico
        • Middle East
        • Middle East - Arabic
        • Netherlands
        • Norway
        • Poland
        • Portugal
        • Russia
        • Slovakia
        • Spain
        • Sweden
        • United States
        • Vietnam

        My Services

        • All News Releases
        • PR Newswire Amplify™
        • Resources
        • Journalists
        • Data Privacy

        Do not sell or share my personal information:

        • Submit via Privacy@cision.com 
        • Call Privacy toll-free: 877-297-8921

        Contact PR Newswire

        Products

        About

        My Services
        • All News Releases
        • Customer Portal
        • Resources
        • Journalists
        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
        • Terms of Use
        • Privacy Policy
        • Information Security Policy
        • Site Map
        • RSS
        • Cookie Settings
        Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.